Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 37 to 45 of 45 entries
Sorted by: Best Match Show Resources per page
New insights into the management of myocardial ischemia. San Francisco, California, November 3-4, 1989. Proceedings of a symposium.

American heart journal

[No authors listed]
PMID: 2389717
Am Heart J. 1990 Sep;120(3):719-72.

No abstract available.

Cite
New insights into the management of myocardial ischemia. San Francisco, California, November 3-4, 1989. Proceedings of a symposium. Am Heart J. 1990;120(3):719-72
(1990). New insights into the management of myocardial ischemia. San Francisco, California, November 3-4, 1989. Proceedings of a symposium. American heart journal, 120(3), 719-72.
"New insights into the management of myocardial ischemia. San Francisco, California, November 3-4, 1989. Proceedings of a symposium." American heart journal vol. 120,3 (1990): 719-72.
New insights into the management of myocardial ischemia. San Francisco, California, November 3-4, 1989. Proceedings of a symposium. Am Heart J. 1990 Sep;120(3):719-72. PMID: 2389717.
Copy Download .nbib Format: NLM
[Medical or surgical treatment of coronary insufficiency].

Revue medicale de Liege

Marchandise B.
PMID: 515601
Rev Med Liege. 1979 Jun;34:34-7.

No abstract available.

Cite
Marchandise B. Traitement médical ou chirurgical de l'insuffisance coronarienne. [Medical or surgical treatment of coronary insufficiency]. Rev Med Liege. 1979;34:34-7
Marchandise, B. (1979). Traitement médical ou chirurgical de l'insuffisance coronarienne. [Medical or surgical treatment of coronary insufficiency]. Revue medicale de Liege, 3434-7.
Marchandise, B. "Traitement médical ou chirurgical de l'insuffisance coronarienne." [Medical or surgical treatment of coronary insufficiency]. Revue medicale de Liege vol. 34 (1979): 34-7.
Marchandise B. Traitement médical ou chirurgical de l'insuffisance coronarienne. [Medical or surgical treatment of coronary insufficiency]. Rev Med Liege. 1979 Jun;34:34-7. French. PMID: 515601.
Copy Download .nbib Format: NLM
Risk factor intervention and coronary artery disease: clinical strategies.

Coronary artery disease

Vogel RA.
PMID: 7551267
Coron Artery Dis. 1995 Jun;6(6):466-71.

No abstract available.

Cite
Vogel RA. Risk factor intervention and coronary artery disease: clinical strategies. Coron Artery Dis. 1995;6(6):466-71
Vogel, R. A. (1995). Risk factor intervention and coronary artery disease: clinical strategies. Coronary artery disease, 6(6), 466-71.
Vogel, R A. "Risk factor intervention and coronary artery disease: clinical strategies." Coronary artery disease vol. 6,6 (1995): 466-71.
Vogel RA. Risk factor intervention and coronary artery disease: clinical strategies. Coron Artery Dis. 1995 Jun;6(6):466-71. PMID: 7551267.
Copy Download .nbib Format: NLM
[Optic neuritis caused by amoproxan].

Bulletin des societes d'ophtalmologie de France

Saraux H, Cavicchi L.
PMID: 5499222
Bull Soc Ophtalmol Fr. 1970 May-Jun;70(5):664-5.

No abstract available.

Cite
Saraux H, Cavicchi L. Névrite optique par l'amoproxan. [Optic neuritis caused by amoproxan]. Bull Soc Ophtalmol Fr. 1970;70(5):664-5
Saraux, H., & Cavicchi, L. (1970). Névrite optique par l'amoproxan. [Optic neuritis caused by amoproxan]. Bulletin des societes d'ophtalmologie de France, 70(5), 664-5.
Saraux, H, and Cavicchi, L. "Névrite optique par l'amoproxan." [Optic neuritis caused by amoproxan]. Bulletin des societes d'ophtalmologie de France vol. 70,5 (1970): 664-5.
Saraux H, Cavicchi L. Névrite optique par l'amoproxan. [Optic neuritis caused by amoproxan]. Bull Soc Ophtalmol Fr. 1970 May-Jun;70(5):664-5. French. PMID: 5499222.
Copy Download .nbib Format: NLM
[A new etiology of toxic optic neuritis: amoproxan].

Bulletin des societes d'ophtalmologie de France

François P, Woillez M, Guilbert, Carouges J.
PMID: 5499223
Bull Soc Ophtalmol Fr. 1970 May-Jun;70(5):665-6.

No abstract available.

Cite
François P, Woillez M, Guilbert, et al. Une nouvelle étiologie de névrite optique toxique: l'amoproxan. [A new etiology of toxic optic neuritis: amoproxan]. Bull Soc Ophtalmol Fr. 1970;70(5):665-6
François, P., Woillez, M., Guilbert, & Carouges, J. (1970). Une nouvelle étiologie de névrite optique toxique: l'amoproxan. [A new etiology of toxic optic neuritis: amoproxan]. Bulletin des societes d'ophtalmologie de France, 70(5), 665-6.
François, P, et al. "Une nouvelle étiologie de névrite optique toxique: l'amoproxan." [A new etiology of toxic optic neuritis: amoproxan]. Bulletin des societes d'ophtalmologie de France vol. 70,5 (1970): 665-6.
François P, Woillez M, Guilbert, Carouges J. Une nouvelle étiologie de névrite optique toxique: l'amoproxan. [A new etiology of toxic optic neuritis: amoproxan]. Bull Soc Ophtalmol Fr. 1970 May-Jun;70(5):665-6. French. PMID: 5499223.
Copy Download .nbib Format: NLM
[Guidelines for the prevention and treatment of coronary artery disease].

Nihon rinsho. Japanese journal of clinical medicine

Kinoshita M, Nakamura Y.
PMID: 12809057
Nihon Rinsho. 2003 May;61:920-4.

No abstract available.

Cite
Kinoshita M, Nakamura Y. [Guidelines for the prevention and treatment of coronary artery disease]. Nihon Rinsho. 2003;61:920-4
Kinoshita, M., & Nakamura, Y. (2003). [Guidelines for the prevention and treatment of coronary artery disease]. Nihon rinsho. Japanese journal of clinical medicine, 61920-4.
Kinoshita, Masahiko, and Nakamura, Yasuyuki. "[Guidelines for the prevention and treatment of coronary artery disease]." Nihon rinsho. Japanese journal of clinical medicine vol. 61 (2003): 920-4.
Kinoshita M, Nakamura Y. [Guidelines for the prevention and treatment of coronary artery disease]. Nihon Rinsho. 2003 May;61:920-4. Japanese. PMID: 12809057.
Copy Download .nbib Format: NLM
Diabetes: coronary heart disease equivalent?.

Current opinion in lipidology

Peter R, Rose A, Anthony S.
PMID: 22241330
Curr Opin Lipidol. 2012 Feb;23(1):80-1. doi: 10.1097/MOL.0b013e32834f42c6.

No abstract available.

Cite
Peter R, Rose A, Anthony S. Diabetes: coronary heart disease equivalent?. Curr Opin Lipidol. 2012;23(1):80-1doi: 10.1097/MOL.0b013e32834f42c6.
Peter, R., Rose, A., & Anthony, S. (2012). Diabetes: coronary heart disease equivalent?. Current opinion in lipidology, 23(1), 80-1. https://doi.org/10.1097/MOL.0b013e32834f42c6
Peter, Rajesh, et al. "Diabetes: coronary heart disease equivalent?." Current opinion in lipidology vol. 23,1 (2012): 80-1. doi: https://doi.org/10.1097/MOL.0b013e32834f42c6
Peter R, Rose A, Anthony S. Diabetes: coronary heart disease equivalent?. Curr Opin Lipidol. 2012 Feb;23(1):80-1. doi: 10.1097/MOL.0b013e32834f42c6. PMID: 22241330.
Copy Download .nbib Format: NLM
Network Pharmacology-Based Exploration of Synergistic Mechanism of Guanxin II Formula (II) for Coronary Heart Disease.

Chinese journal of integrative medicine

Sheng S, Yang ZX, Xu FQ, Huang Y.
PMID: 32388823
Chin J Integr Med. 2021 Feb;27(2):106-114. doi: 10.1007/s11655-020-3199-z. Epub 2020 May 09.

OBJECTIVE: To study the pharmacological mechanism of Guanxin II formula (II) for treatment of coronary heart disease (CHD).METHODS: A network pharmacology-based method was utilized. First candidate compounds, targets of GX II were collected using PharmMapper, BATMAN-TCM, DrugBank and SwissTargetPrediction,...

Cite
Sheng S, Yang ZX, Xu FQ, et al. Network Pharmacology-Based Exploration of Synergistic Mechanism of Guanxin II Formula (II) for Coronary Heart Disease. Chin J Integr Med. 2020;27(2):106-114doi: 10.1007/s11655-020-3199-z.
Sheng, S., Yang, Z. X., Xu, F. Q., & Huang, Y. (2021). Network Pharmacology-Based Exploration of Synergistic Mechanism of Guanxin II Formula (II) for Coronary Heart Disease. Chinese journal of integrative medicine, 27(2), 106-114. https://doi.org/10.1007/s11655-020-3199-z
Sheng, Song, et al. "Network Pharmacology-Based Exploration of Synergistic Mechanism of Guanxin II Formula (II) for Coronary Heart Disease." Chinese journal of integrative medicine vol. 27,2 (2021): 106-114. doi: https://doi.org/10.1007/s11655-020-3199-z
Sheng S, Yang ZX, Xu FQ, Huang Y. Network Pharmacology-Based Exploration of Synergistic Mechanism of Guanxin II Formula (II) for Coronary Heart Disease. Chin J Integr Med. 2021 Feb;27(2):106-114. doi: 10.1007/s11655-020-3199-z. Epub 2020 May 09. PMID: 32388823.
Copy Download .nbib Format: NLM
Clinical management of asymptomatic myocardial ischemia.

Pharmacotherapy

Touchon R.
PMID: 3324062
Pharmacotherapy. 1987;7(5):76S-82S. doi: 10.1002/j.1875-9114.1987.tb04054.x.

Silent myocardial ischemia, an important contributor to myocardial infarction, sudden cardiac death, ischemic arrhythmias, and other aspects of cardiac morbidity and mortality, requires treatment. Two pathophysiologic mechanisms have been proposed to explain transient, acute episodes of myocardial ischemia: an...

Cite
Touchon R. Clinical management of asymptomatic myocardial ischemia. Pharmacotherapy. 1987;7(5):76S-82Sdoi: 10.1002/j.1875-9114.1987.tb04054.x.
Touchon, R. (1987). Clinical management of asymptomatic myocardial ischemia. Pharmacotherapy, 7(5), 76S-82S. https://doi.org/10.1002/j.1875-9114.1987.tb04054.x
Touchon, R. "Clinical management of asymptomatic myocardial ischemia." Pharmacotherapy vol. 7,5 (1987): 76S-82S. doi: https://doi.org/10.1002/j.1875-9114.1987.tb04054.x
Touchon R. Clinical management of asymptomatic myocardial ischemia. Pharmacotherapy. 1987;7(5):76S-82S. doi: 10.1002/j.1875-9114.1987.tb04054.x. PMID: 3324062.
Copy Download .nbib Format: NLM
Showing 37 to 45 of 45 entries